Crossmark

Perioperative Modified FLOT Versus EOX in Locally Advanced Resectable Gastric and Gastro-Oesophageal Junction Adenocarcinoma: Results of a Matched-Pair Analysis

Crossref DOI link: https://doi.org/10.1007/s12029-022-00867-3

Published Online: 2022-10-15

Published Print: 2023-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ramaswamy, Anant

Bhargava, Prabhat

Srinivas, Sujay

Kannan, Sadhana

Bhandare, Manish

Chaudhari, Vikram

Mantri, Anoop

Kapoor, Akhil

Das, Sudeep

Booma, Naveen

Chaugule, Deepali

Shrikhande, Shailesh V.

Ostwal, Vikas
License Information

Text and Data Mining valid from 2022-10-15

Version of Record valid from 2022-10-15
More Information

Article History

Accepted: 25 September 2022

First Online: 15 October 2022

Declarations

:

: The authors declare no competing interests.

: The current study was conducted after Institutional Review Board (IRB) approval of a project evaluating outcomes of patients with EGAC being treated with perioperative chemotherapy (IEC/900711).

: The authors declare no competing interests.

Document is current

Any future updates will be listed below